460 related articles for article (PubMed ID: 21549790)
21. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
22. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
23. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
24. A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting.
Chrun T; Lacôte S; Urien C; Richard CA; Tenbusch M; Aubrey N; Pulido C; Lakhdar L; Marianneau P; Schwartz-Cornil I
Front Immunol; 2019; 10():860. PubMed ID: 31105695
[TBL] [Abstract][Full Text] [Related]
25. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
26. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
27. A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity.
Holman DH; Penn-Nicholson A; Wang D; Woraratanadharm J; Harr MK; Luo M; Maher EM; Holbrook MR; Dong JY
Clin Vaccine Immunol; 2009 Nov; 16(11):1624-32. PubMed ID: 19776190
[TBL] [Abstract][Full Text] [Related]
28. Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice.
Jansen van Vuren P; Tiemessen CT; Paweska JT
PLoS One; 2011; 6(9):e25027. PubMed ID: 21949840
[TBL] [Abstract][Full Text] [Related]
29. Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins.
Ayari-Fakhfakh E; Ghram A; Albina E; Cêtre-Sossah C
Vet Immunol Immunopathol; 2018 Mar; 197():15-20. PubMed ID: 29475501
[TBL] [Abstract][Full Text] [Related]
30. Virus-like particle-based countermeasures against Rift Valley fever virus.
Koukuntla R; Mandell RB; Flick R
Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.
Kortekaas J; Dekker A; de Boer SM; Weerdmeester K; Vloet RP; de Wit AA; Peeters BP; Moormann RJ
Vaccine; 2010 Mar; 28(11):2271-6. PubMed ID: 20079874
[TBL] [Abstract][Full Text] [Related]
32. A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.
Faburay B; Wilson WC; Gaudreault NN; Davis AS; Shivanna V; Bawa B; Sunwoo SY; Ma W; Drolet BS; Morozov I; McVey DS; Richt JA
Sci Rep; 2016 Jun; 6():27719. PubMed ID: 27296136
[TBL] [Abstract][Full Text] [Related]
33. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
34. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
[TBL] [Abstract][Full Text] [Related]
35. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
36. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
[TBL] [Abstract][Full Text] [Related]
37. Production of monoclonal antibodies against Rift Valley fever virus Application for rapid diagnosis tests (virus detection and ELISA) in human sera.
Zaki A; Coudrier D; Yousef AI; Fakeeh M; Bouloy M; Billecocq A
J Virol Methods; 2006 Jan; 131(1):34-40. PubMed ID: 16102851
[TBL] [Abstract][Full Text] [Related]
38. Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine.
Morrill JC; Peters CJ
J Infect Dis; 2011 Aug; 204(4):617-25. PubMed ID: 21791664
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice.
Papin JF; Verardi PH; Jones LA; Monge-Navarro F; Brault AC; Holbrook MR; Worthy MN; Freiberg AN; Yilma TD
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14926-31. PubMed ID: 21873194
[TBL] [Abstract][Full Text] [Related]
40. Chimaeric Rift Valley Fever Virus-Like Particle Vaccine Candidate Production in Nicotiana benthamiana.
Mbewana S; Meyers AE; Rybicki EP
Biotechnol J; 2019 Apr; 14(4):e1800238. PubMed ID: 30488669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
